Cargando…
The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene
PURPOSE: To measure visual fields using two-color dark-adapted chromatic perimetry in a subset of participants in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A), a study of USH2A-mediated syndromic (USH2) and autosomal recessive nonsyndromic retinitis pigmentosa, determine pe...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944389/ https://www.ncbi.nlm.nih.gov/pubmed/35293952 http://dx.doi.org/10.1167/iovs.63.3.17 |
_version_ | 1784673703272906752 |
---|---|
author | Birch, David G. Samarakoon, Lassana Melia, Michele Duncan, Jacque L. Ayala, Allison R. Audo, Isabelle Cheetham, Janet K. Durham, Todd A. Iannaccone, Alessandro Pennesi, Mark E. Stingl, Katarina |
author_facet | Birch, David G. Samarakoon, Lassana Melia, Michele Duncan, Jacque L. Ayala, Allison R. Audo, Isabelle Cheetham, Janet K. Durham, Todd A. Iannaccone, Alessandro Pennesi, Mark E. Stingl, Katarina |
author_sort | Birch, David G. |
collection | PubMed |
description | PURPOSE: To measure visual fields using two-color dark-adapted chromatic perimetry in a subset of participants in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A), a study of USH2A-mediated syndromic (USH2) and autosomal recessive nonsyndromic retinitis pigmentosa, determine percentage retaining rod function, and explore relationships between dark-adapted visual fields (DAVF) and rod function from ERG and full-field stimulus thresholds (FST). METHODS: Full-field rod mean sensitivity, number of rod loci, maximum sensitivity, DAVF full-field hill of vision (DAVF V(TOT)), and 30° hill of vision (DAVF V(30)) were measured in one eye for DAVF ancillary study participants (n = 49). Loci where cyan relative to red sensitivity was more than 5 dB on dark-adapted chromatic perimetry were considered rod mediated. Correlation coefficients between the DAVF measures and standard clinical measures were estimated, as were kappa statistics (κ) for agreement between DAVF and other measures of rod function. RESULTS: Of 49 participants tested with DAVF, 38 (78%) had evidence of rod function, whereas 15 (31%) had measurable rod ERGs. DAVF maximum sensitivity was highly correlated with FST white thresholds (r = −0.80; P < .001). Although not statistically significant, the number of rod loci and DAVF V(TOT) were lower in eyes with longer disease duration by 0.82 (95% confidence interval, −1.76, 0.12) loci/year and 0.59 (95% confidence interval, −1.82, 0.64) dB-steradians/year, respectively. CONCLUSIONS: Rod-mediated function on FST and DAVF is present in many patients with symptomatic USH2A-related retinal degeneration, including some without measurable rod ERGs. RUSH2A longitudinal data will determine how these measures change with disease progression and whether they are useful for longitudinal studies in inherited retinal degenerations. |
format | Online Article Text |
id | pubmed-8944389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-89443892022-03-25 The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene Birch, David G. Samarakoon, Lassana Melia, Michele Duncan, Jacque L. Ayala, Allison R. Audo, Isabelle Cheetham, Janet K. Durham, Todd A. Iannaccone, Alessandro Pennesi, Mark E. Stingl, Katarina Invest Ophthalmol Vis Sci Retina PURPOSE: To measure visual fields using two-color dark-adapted chromatic perimetry in a subset of participants in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A), a study of USH2A-mediated syndromic (USH2) and autosomal recessive nonsyndromic retinitis pigmentosa, determine percentage retaining rod function, and explore relationships between dark-adapted visual fields (DAVF) and rod function from ERG and full-field stimulus thresholds (FST). METHODS: Full-field rod mean sensitivity, number of rod loci, maximum sensitivity, DAVF full-field hill of vision (DAVF V(TOT)), and 30° hill of vision (DAVF V(30)) were measured in one eye for DAVF ancillary study participants (n = 49). Loci where cyan relative to red sensitivity was more than 5 dB on dark-adapted chromatic perimetry were considered rod mediated. Correlation coefficients between the DAVF measures and standard clinical measures were estimated, as were kappa statistics (κ) for agreement between DAVF and other measures of rod function. RESULTS: Of 49 participants tested with DAVF, 38 (78%) had evidence of rod function, whereas 15 (31%) had measurable rod ERGs. DAVF maximum sensitivity was highly correlated with FST white thresholds (r = −0.80; P < .001). Although not statistically significant, the number of rod loci and DAVF V(TOT) were lower in eyes with longer disease duration by 0.82 (95% confidence interval, −1.76, 0.12) loci/year and 0.59 (95% confidence interval, −1.82, 0.64) dB-steradians/year, respectively. CONCLUSIONS: Rod-mediated function on FST and DAVF is present in many patients with symptomatic USH2A-related retinal degeneration, including some without measurable rod ERGs. RUSH2A longitudinal data will determine how these measures change with disease progression and whether they are useful for longitudinal studies in inherited retinal degenerations. The Association for Research in Vision and Ophthalmology 2022-03-16 /pmc/articles/PMC8944389/ /pubmed/35293952 http://dx.doi.org/10.1167/iovs.63.3.17 Text en Copyright 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Retina Birch, David G. Samarakoon, Lassana Melia, Michele Duncan, Jacque L. Ayala, Allison R. Audo, Isabelle Cheetham, Janet K. Durham, Todd A. Iannaccone, Alessandro Pennesi, Mark E. Stingl, Katarina The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene |
title | The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene |
title_full | The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene |
title_fullStr | The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene |
title_full_unstemmed | The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene |
title_short | The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene |
title_sort | rush2a study: dark-adapted visual fields in patients with retinal degeneration associated with biallelic variants in the ush2a gene |
topic | Retina |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944389/ https://www.ncbi.nlm.nih.gov/pubmed/35293952 http://dx.doi.org/10.1167/iovs.63.3.17 |
work_keys_str_mv | AT birchdavidg therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT samarakoonlassana therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT meliamichele therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT duncanjacquel therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT ayalaallisonr therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT audoisabelle therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT cheethamjanetk therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT durhamtodda therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT iannacconealessandro therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT pennesimarke therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT stinglkatarina therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT birchdavidg rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT samarakoonlassana rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT meliamichele rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT duncanjacquel rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT ayalaallisonr rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT audoisabelle rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT cheethamjanetk rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT durhamtodda rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT iannacconealessandro rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT pennesimarke rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT stinglkatarina rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene AT rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene |